Pivotal role focused on channeling scientific capabilities to bring assets to patients across the globe. Responsible for developing and driving the overall commercialization plans across indications and tumor areas for lung cancer.
Compensation
The annual base pay for this position ranges from $267,913 - 401,870 USD.
Responsibilities
Accountable for commercial strategy and its success in the Lung cancer indications.
Develop, shape, evolve and implement resources and programs to support the full commercial range of lifecycle deliverables
Work with core markets to prepare for / deliver on all commercialization and launch programs for Lung cancer indications
Build and shape capabilities in global and in markets to drive state of the art commercialization
Represent Lung business perspectives to cross functional teams, senior executives and governance committees
Requirements
Bachelor's degree in a relevant field, such as business or life sciences
Lead global commercialization strategy for lung cancer across markets and teams.
Compensation
The annual base pay for this position ranges from $267,913 - 401,870 USD. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles.
Responsibilities
Accountable for commercial strategy and its success in the Lung cancer indications
Develop, shape, evolve and implement resources and programs to support the full commercial range of lifecycle deliverables
Work with core markets to prepare for / deliver on all commercialization and launch programs for Lung cancer indications
Build and shape capabilities in global and in markets to drive state of the art commercialization
Represent Lung business perspectives to cross functional teams, senior executives and governance committees
Requirements
Bachelor's degree in a relevant field, such as business or life sciences
A pivotal legal role focused on protecting scientific discoveries, driving strategic IP decisions, and building patent portfolios in partnering with R&D teams.
Locations (2)
Basel, Basel-Stadt, Switzerland
Cambridge, Massachusetts, United States
Compensation
Expected Annual Base Salary Range for role: CHF 126.000 - CHF 234.000
Responsibilities
Provide clear, strategic, and business-focused counsel to Novartis R&D clients on invention protection, portfolio development, publication strategy, and third-party risks.
Build and manage patent portfolios for Novartis R&D projects by identifying inventions and preparing, prosecuting, maintaining, and defending patent filings across areas such as new molecular entities, processes, manufacturing, platforms, technologies, and clinical developments.
Render legal opinions on patentability, validity, and freedom to operate, and develop patent strategies that strengthen IP positions, support freedom to operate, and enable effective IP defense.
Provide analytical support to the client’s drug substance manufacturing and method development services, involving project analysis, method development, forced degradation studies and proof of concept method validation.
Responsibilities
Provide analytical support for Eurofins’ drug substance manufacturing and method development projects
Perform project analysis, method development activities, forced degradation studies, proof of concept validation work, and data interpretation
Contribute to the authoring and review of key analytical documentation
Work independently and collaboratively within a multidisciplinary team
Apply strong technical expertise and problem-solving skills to investigate challenges
Leading CMC regulatory strategy development and implementation incorporating risk identification and mitigation for assigned development and post-approval programs to achieve regulatory approvals in the EMEA region.
Compensation
$164,000.00-213,000.00 Annual
Responsibilities
Plan and coordinate regulatory submissions to support projects in development and commercial applications, including lifecycle management of products in the EMEA region.
Work closely with cross-functional teams to ensure short and long term objectives are achieved.
Lead the development of CMC background documentation for consultation with the EMA, MHRA and other regulatory authorities.
Identify key CMC content requirements and author the CMC sections for IND/IMPD, NDA/MAA, and other regulatory submissions.
Establish product specific strategies to ensure successful development of CMC submission packages to support early development, registration and life cycle management.
The Principal Engineer will serve as a senior technical leader and subject matter expert within Pharmaceutical Development, representing Technical Operations on cross-functional project teams focusing on late-stage development, process optimization, scale-up, and control strategy.
Compensation
The annual base salary we reasonably expect to pay is $156,900.00-$214,000.00. In addition, this position offers an annual bonus with a target of 30% of the earned base salary and eligibility to participate in our equity based long term incentive program.
Responsibilities
Serve as a scientific subject matter expert in process engineering and pharmaceutical development of solid oral drug products
Design and develop fit-for-purpose phase-appropriate processes (granulation, encapsulation, tablet compression, coating, spray drying, hot melt extrusion, etc.)
Apply broad pharmaceutical development experience to identify process development risks (FMEA), evaluate experimental findings, and recommend strategies
Provide independent scientific review of experimental designs, analytical data, electronic laboratory notebooks, technical reports, and regulatory documentation
Translating global and hub priorities into impactful country-level action, strengthening performance, driving operational excellence, and leading strategic initiatives for clinical study execution.
Compensation
Salary Range: €63,600.00 - €118,000.00
Responsibilities
Translate global and hub SMM strategy into clear country priorities, plans, and measurable outcomes.
Drive strategic initiatives that strengthen clinical study execution, operational excellence, productivity, and performance.
Identify country-specific opportunities, risks, and challenges, developing solutions that support effective mitigation.
Lead innovation, transformation, and change initiatives that improve processes, efficiency, and ways of working.
Use business insights, metrics, and external trends to guide strategic decisions and performance improvements.
Requirements
Bachelor's degree in life sciences
Nice to have: Advanced degree in a scientific or business-related discipline
The Project Management Group Leader is responsible for managing and delivering complex customer programs for oral solid dosage pharmaceutical products, as well as leading the Italy PM team. This role combines direct people management with ownership of selected strategic projects, site portfolio oversight, and cross-functional leadership.
Responsibilities
Directly supervise, coach and develop a small team of PMs
establish objectives and individual development plans
Lead Medical Director responsible for developing and executing late-stage clinical development strategies and plans for assigned molecules in hematology, ensuring alignment with regulatory and business objectives.
Locations (2)
South San Francisco, California, United States
San Francisco, California, United States
Compensation
The expected salary range for this position based on the primary location of San Francisco, CA $233,500 - $433,600. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance.
Responsibilities
Develop and execute Clinical Development strategy and plan
Support implementation of Clinical Development Plan (CDP) for assigned molecules
Collaborate with internal and external partners across business development, research, commercial, legal, and regulatory teams
Provide clinical science input and guidance for early development and Phase I studies